|
|||||
|
|
Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the CRYSTEL study |
|
| Authors: | C.E.M. Griffiths T.A. Luger Y. Brault J.M. Germain L. Mallbris |
| Affiliation: | 1. Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK;2. Department of Dermatology, University of Muenster, Muenster, Germany;3. Pfizer PGRD, Paris, France;4. Pfizer, Pfizer International Operations, Paris, France;5. Global Medical Affairs, Global Innovative Pharma, Pfizer Inc, Collegeville, PA, USA |
| Abstract: | |
| Keywords: | |